Tecfidera, MS Drug, Yakabatsira Biogen Profit; Kambani Inotumira 26% Kuvhiya Mumari Yegore
Tecfidera, MS Drug, Yakabatsira Biogen Profit; Kambani Inotumira 26% Kuvhiya Mumari Yegore
Anonim

Masayendisiti kuBiogen Idec Inc. anofanira kunge achisimudza magirazi echampagne nhasi mushure mekuzivisa kwekambani purofiti yekupera kwegore. Biogen yakatumira kuwedzera kwe26 muzana pamusoro pemari yegore rapfuura, kuvhiya kunoshamisa nekuda kwechikamu chekukura nekukurumidza kweTecfidera, kambani yeOral multiple sclerosis (MS) mushonga, iyo yakawana kutengesa kwakazara kwemadhora mazana masere nemakumi masere nematanhatu ega. "2013 raive gore rakanaka kuBiogen Idec nevarwere vatinoshandira," akadaro CEO George A. Scangos. Tecfidera, iyo yave iri kutengesa-pamusoro muromo MS kurapwa muUS, yakatemerwa nevanopfuura zviuru zvitanhatu vanachiremba kusvika pari zvino, sekureva kweReuters.

Tecfidera, kana dimethyl fumarate, inoderedza kudzokororwa uye kukura kwezvironda zvehuropi mukuwedzera pakunonotsa kufambira mberi kwehurema nekufamba kwenguva. Zvinowanzoitika zvinosanganisira kunyorova kusvika pakati nepakati kurutsa uye manyoka, kuda kurutsa, uye kurwadziwa nemudumbu. Mushonga wacho wakabvumirwa neFood and Drug Administration yekurapa mafomu ekudzokazve kwemultiple sclerosis, kusanganisira relapsing-remitting multiple sclerosis, inowanzonzi RRMS, iyo inowanzozivikanwa yechirwere.

Chirwere Chekudzivirira Dziviriro

MS chirwere chisingaperi, chinowanzoremadza chinorwisa tsinga dzepakati, dzinoumbwa neuropi, musana, uye tsinga dzemaziso. Nepo mamwe masayendisiti achitenda kuti MS ihosha yeautoimmune, asi nekuda kwekuti chinangwa chekurwisa hachisati chaonekwa, mamwe masayendisiti haabvumirane uye nekuda kweichi chikonzero, MS inonzi ihosha inodzivirira muviri. Zviratidzo zvinotangira pakuva nechiveve mumakumbo kusvika pakuoma mitezo kana kutotadza kuona. Kufambira mberi, kuoma, uye zviratidzo zvakananga zveMS zvinosiyana kubva kune mumwe munhu kuenda kune anotevera. Kunyangwe chirwere ichi chichifungidzirwa kuva genetic, chinokonzeresa mumunhu ane hutachiona nekubatanidzwa kwechimwe kana zvimwe zvakatipoteredza.

Vanachiremba vanopatsanura MS kuita makosi mana, nevarwere vane madhigirii akasiyana ekuomarara kune imwe neimwe: relapsing-remitting MS; primary-progressive MS; sekondari-inofambira mberi MS; uye inofambira mberi-inodzokororazve MS. Inenge 85 muzana yevanhu vanotanga kuonekwa kuti vane RRMS, umo varwere vanoona zvakajeka kurwiswa kwehupi hupi hupi hupi hupi hupi hunoteverwa nekanguva kana kuti yakakwana yekudzorera nguva (kuregererwa). Vanosvika 10 muzana yevanhu vanoonekwa kuti vane MS yekutanga-inofambira mberi, umo mune kungowedzera kuwedzera kwezviratidzo zveurologic minus kuregererwa. Kune varwere vazhinji, mushure mekuongororwa kwekutanga kweRRMS, vanopinda mune yechipiri-inofambira mberi kosi panguva iyo chirwere chinowedzera kuipa, kana pasina dzimwe nguva flare-ups, kuregererwa kudiki, kana mapani. Biogen, kambani yebiotechnology yakavambwa muna 1978, yakatarisana nekuedza kwayo kweR&D pakurapa kwevarwere vane neurodegenerative chirwere, hemophilia, uye autoimmune kusagadzikana, kusanganisira pakati pezvigadzirwa zvayo maviri anozivikanwa majekiseni eMS emishonga, Avonex neTysabri.

Gare gare muna 2014, Biogen ichatanga kuona yekutanga-kusvika-pakati nhanho yekiriniki yekuyedza data kune akati wandei angangove ekugadzirisa zvinodhaka munzvimbo yechirwere cheAlzheimer's, idiopathic pulmonary fibrosis, MS, spinal muscular atrophy, uye lupus. Scangos akati, "Tiri kupinda munguva inofadza apo tiri kuronga zvinhu zvitatu zvingangove zvichitangwa gore rino, kusanganisira marapirwo maviri evarwere vane hemophilia uye yekutanga pegylated interferon yeMS - pamwe nekubvumidzwa uye kutangwa kweTECFIDERA muEurope.” Mushonga uyu wakatobvumidzwa uye kutengeswa kuCanada neAustralia.

Yakakurumbira nenyaya